VRVIX
Price
$437.79
Change
+$3.91 (+0.90%)
Updated
Sep 11 closing price
Net Assets
23.88B
VVIAX
Price
$87.39
Change
+$0.67 (+0.77%)
Updated
Sep 11 closing price
Net Assets
262.3B
Interact to see
Advertisement

VRVIX vs VVIAX

VRVIX vs VVIAX Comparison Chart in %
View a ticker or compare two or three
VS
VRVIX vs. VVIAX commentary
Sep 12, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is VRVIX is a Buy and VVIAX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VVIAX has more cash in the bank: 262B vs. VRVIX (23.9B). VVIAX pays higher dividends than VRVIX: VVIAX (1.81) vs VRVIX (1.53). VRVIX was incepted earlier than VVIAX: VRVIX (16 years) vs VVIAX (26 years). VRVIX (0.05) and VVIAX (0.05) have similar cost to investors . VRVIX is a more actively managed with annual turnover of: 17.00 vs. VVIAX (8.00). VVIAX has a lower initial minimum investment than VRVIX: VVIAX (3000) vs VRVIX (5000000). VRVIX annual gain was more profitable for investors over the last year : 24.36 vs. VVIAX (19.53). VVIAX (60.72) and VRVIX (58.80) have equivalent 5 years return.
VRVIXVVIAXVRVIX / VVIAX
Total Expense Ratio0.050.05100%
Annual Report Gross Expense Ratio0.050.05100%
Fund Existence16 years26 years-
Gain YTD20.46516.387125%
Front LoadN/AN/A-
Min. Initial Investment50000003000166,667%
Min. Initial Investment IRAN/AN/A-
Net Assets23.9B262B9%
Annual Yield % from dividends1.531.8185%
Returns for 1 year24.3619.53125%
Returns for 3 years60.7355.72109%
Returns for 5 years58.8060.7297%
Returns for 10 years145.16160.5990%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
FDFAX92.06N/A
N/A
Fidelity Select Consumer Staples Port
GSGCX51.28N/A
N/A
Goldman Sachs Equity Income C
TISEX23.40N/A
N/A
Nuveen Quant Small Cap Equity R6
BSPSX883.20N/A
N/A
iShares S&P 500 Index Service
VVJEX12.16N/A
N/A
Voya VACS Series MCV Fund